Natixis Advisors L.P. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,792 shares of the biotechnology company’s stock after acquiring an additional 3,468 shares during the quarter. Natixis Advisors L.P.’s holdings in Axon Enterprise were worth $6,404,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. grew its position in Axon Enterprise by 8.9% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,716 shares of the biotechnology company’s stock valued at $1,535,000 after purchasing an additional 630 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of Axon Enterprise by 2.3% in the third quarter. Mackenzie Financial Corp now owns 6,292 shares of the biotechnology company’s stock valued at $1,208,000 after acquiring an additional 141 shares during the last quarter. Advisor Partners II LLC raised its holdings in Axon Enterprise by 3.5% during the third quarter. Advisor Partners II LLC now owns 3,407 shares of the biotechnology company’s stock worth $678,000 after acquiring an additional 115 shares in the last quarter. Park Avenue Securities LLC acquired a new position in Axon Enterprise during the third quarter valued at approximately $828,000. Finally, TD Asset Management Inc grew its stake in Axon Enterprise by 3.0% in the third quarter. TD Asset Management Inc now owns 22,342 shares of the biotechnology company’s stock valued at $4,446,000 after purchasing an additional 645 shares in the last quarter. 79.08% of the stock is owned by institutional investors.
Axon Enterprise Price Performance
NASDAQ:AXON opened at $309.09 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The firm has a market cap of $23.32 billion, a price-to-earnings ratio of 90.38 and a beta of 0.91. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The firm’s 50-day simple moving average is $310.86 and its 200 day simple moving average is $267.73.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Monday, May 6th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm’s quarterly revenue was up 34.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.51 earnings per share. As a group, sell-side analysts predict that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.
Wall Street Analyst Weigh In
Several analysts have issued reports on AXON shares. TheStreet lowered shares of Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Morgan Stanley raised their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. JPMorgan Chase & Co. lifted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, JMP Securities reiterated a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research note on Tuesday. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $333.08.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
